Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
342
archived clinical trials in
Restless Leg Syndrome

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Neurology Associates of Ormond Beach
mi
from
Ormond Beach, FL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Neurology Associates of Ormond Beach
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Resurgence Group
mi
from
Palm Harbor, FL
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Resurgence Group
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Georgia Health Sciences University
mi
from
Augusta, GA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
SleepMed of Central Georgia
mi
from
Macon, GA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
SleepMed of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Community Research
mi
from
Crestview Hills, KY
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Community Research
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Kentucky Research Group
mi
from
Louisville, KY
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Kentucky Research Group
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Johns Hopkins Bayview Medical Center Campus
mi
from
Baltimore, MD
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Johns Hopkins Bayview Medical Center Campus
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep Health Centers
mi
from
Brighton, MA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep Health Centers
mi
from
Brighton, MA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Beacon Clinical Research, LLC
mi
from
Brockton, MA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Beacon Clinical Research, LLC
mi
from
Brockton, MA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
QUEST Research Institute
mi
from
Farmington Hills, MI
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
QUEST Research Institute
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Global Medical Institutes, Llc
mi
from
Princeton, NJ
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Global Medical Institutes, Llc
mi
from
Princeton, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Fieve Clinical Research
mi
from
New York, NY
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Fieve Clinical Research
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Comprehensive Multiple Sclerosis Care Center
mi
from
Patchogue, NY
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Comprehensive Multiple Sclerosis Care Center
mi
from
Patchogue, NY
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Raleigh Neurology Associates
mi
from
Raleigh, NC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
PMG Research of Wilmington
mi
from
Wilmington, NC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Community Research
mi
from
Cincinnati, OH
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Community Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep Lab of Northeastern Pennsylvania
mi
from
Clarks Summit, PA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep Lab of Northeastern Pennsylvania
mi
from
Clarks Summit, PA
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
SleepMed of SC
mi
from
Columbia, SC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
SleepMed of SC
mi
from
Columbia, SC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Coastal Carolina Research Center
mi
from
Mt. Pleasant, SC
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Coastal Carolina Research Center
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
University of Tennesee Health Science Center
mi
from
Memphis, TN
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
University of Tennesee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Future Research Trials of Neurology
mi
from
Austin, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Future Research Trials of Neurology
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Clinical Trial Network
mi
from
Houston, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Bhupesh Dihenia, M.D., P.A.
mi
from
Lubbock, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Bhupesh Dihenia, M.D., P.A.
mi
from
Lubbock, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Paragon Research Center
mi
from
San Antonio, TX
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Paragon Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  1/31/2017
Sleep Medicine Associates
mi
from
Seattle, WA
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 1/31/2017
Sleep Medicine Associates
mi
from
Seattle, WA
Click here to add this to my saved trials
Glutamate, Hyperarousal and Restless Legs Syndrome
Glutamate, Hyperarousal and Restless Legs Syndrome
Status: Enrolling
Updated:  2/28/2017
Johns Hopkins Baview Medical
mi
from
Baltimore, MD
Glutamate, Hyperarousal and Restless Legs Syndrome
Glutamate, Hyperarousal and Restless Legs Syndrome
Status: Enrolling
Updated: 2/28/2017
Johns Hopkins Baview Medical
mi
from
Baltimore, MD
Click here to add this to my saved trials
Glutamate, Hyperarousal and Restless Legs Syndrome
Glutamate, Hyperarousal and Restless Legs Syndrome
Status: Enrolling
Updated:  2/28/2017
Johns Hopkins Bayview Medical Campus
mi
from
Baltimore, MD
Glutamate, Hyperarousal and Restless Legs Syndrome
Glutamate, Hyperarousal and Restless Legs Syndrome
Status: Enrolling
Updated: 2/28/2017
Johns Hopkins Bayview Medical Campus
mi
from
Baltimore, MD
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 006
mi
from
Little Rock, AR
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 006
mi
from
Little Rock, AR
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 012
mi
from
Los Angeles, CA
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 012
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 009
mi
from
Orange, CA
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 009
mi
from
Orange, CA
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 005
mi
from
Washington,
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 005
mi
from
Washington,
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 014
mi
from
Spring Hill, FL
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 014
mi
from
Spring Hill, FL
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 013
mi
from
Indianapolis, IN
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 013
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 001
mi
from
Destrehan, LA
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 001
mi
from
Destrehan, LA
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 015
mi
from
Saint Louis, MO
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 015
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 007
mi
from
West Seneca, NY
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 007
mi
from
West Seneca, NY
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 002
mi
from
Cincinnati, OH
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 002
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 016
mi
from
West Chester, PA
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 016
mi
from
West Chester, PA
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 003
mi
from
Austin, TX
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 003
mi
from
Austin, TX
Click here to add this to my saved trials